Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00942396 | Study to Compare the Diagnostic Accuracy of Nuance Full-Field Digital Mammography to Screen-Film Mammography | withdrawn | Phase 3 | 250 | Planmed OyINDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT01194193 | Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours | withdrawn | Phase 1 | 63 | AstraZenecaINDUSTRY | 0 | May 16, 2011 | clinicaltrials |
| NCT00577668 |
| A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD) |
| withdrawn |
| Phase 2 |
| 0 |
| University of ArkansasOTHER |
| 1 |
| May 3, 2011 |
| clinicaltrials |
| NCT00159016 | Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study. | withdrawn | Phase 2 | 100 | Hadassah Medical OrganizationOTHER | 1 | Apr 28, 2011 | clinicaltrials |
| NCT00162513 | Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia | withdrawn | Phase 1 / Phase 2 | — | Hadassah Medical OrganizationOTHER | 1 | Apr 28, 2011 | clinicaltrials |
| NCT00148993 | Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors | withdrawn | Phase 1 / Phase 2 | 100 | Hadassah Medical OrganizationOTHER | 1 | Apr 8, 2011 | clinicaltrials |
| NCT00149019 | Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies. | withdrawn | Phase 2 | 12 | Hadassah Medical OrganizationOTHER | 1 | Apr 8, 2011 | clinicaltrials |
| NCT00149032 | Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host | withdrawn | Phase 2 | 50 | Hadassah Medical OrganizationOTHER | 1 | Apr 8, 2011 | clinicaltrials |
| NCT00226512 | To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning | withdrawn | Phase 3 | 203 | Hadassah Medical OrganizationOTHER | 1 | Apr 8, 2011 | clinicaltrials |
| NCT00310882 | Involvement of Endogenous Digitalis-like Compounds in Breast Cancer | withdrawn | — | 250 | Hadassah Medical OrganizationOTHER | 1 | Apr 8, 2011 | clinicaltrials |
| NCT00348842 | Newcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional Anti-cancer Modalities | withdrawn | Phase 2 | — | Hadassah Medical OrganizationOTHER | 1 | Apr 8, 2011 | clinicaltrials |
| NCT01012804 | Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer | withdrawn | — | 0 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00728533 | Open-Label, Randomised Parallel-Group Study | withdrawn | Phase 3 | 0 | Ferring PharmaceuticalsINDUSTRY | 0 | Mar 18, 2011 | clinicaltrials |
| NCT01170052 | Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL) | withdrawn | Phase 1 / Phase 2 | 20 | Charite University, Berlin, GermanyOTHER | 1 | Mar 16, 2011 | clinicaltrials |
| NCT00863096 | Human Papillomavirus Screening and Vaccine Readiness Program | withdrawn | — | 450 | Public Health Research Institute, IndiaOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT00252811 | A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer | withdrawn | Phase 2 | 60 | AstraZenecaINDUSTRY | 1 | Jan 28, 2011 | clinicaltrials |
| NCT00233623 | Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer | withdrawn | Phase 2 | 190 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00233636 | Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck | withdrawn | Phase 2 | 28 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00754104 | Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors | withdrawn | Phase 1 | 0 | AbbottINDUSTRY | 0 | Jan 19, 2011 | clinicaltrials |
| NCT00594971 | A Shared Care Approach for Seriously Ill Cancer Patients Between General Practice, Discharge Department and a Specialist Palliative Care Team | withdrawn | N/A | 270 | University of AarhusOTHER | 0 | Jan 11, 2011 | clinicaltrials |
| NCT00888082 | Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy(PROOF) | withdrawn | Phase 3 | 102 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT00162500 | A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies | withdrawn | Phase 2 | 15 | Hadassah Medical OrganizationOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT01015521 | Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer | withdrawn | Phase 2 | 50 | Tigris PharmaceuticalsINDUSTRY | 0 | Nov 3, 2010 | clinicaltrials |
| NCT00053040 | Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas | withdrawn | Phase 1 / Phase 2 | 0 | Pediatric Brain Tumor ConsortiumNETWORK | 0 | Sep 24, 2010 | clinicaltrials |
| NCT00329472 | Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer | withdrawn | Phase 3 | 0 | Samsung Medical CenterOTHER | 0 | Aug 27, 2010 | clinicaltrials |
| NCT01124500 | Transdermal Methylphenidate for Cancer-Related Fatigue | withdrawn | N/A | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Aug 26, 2010 | clinicaltrials |
| NCT00460837 | Comparison of Bowel Preparation in Virtual Colonoscopy (VC) - Patient Experience | withdrawn | Phase 4 | 150 | London North West Healthcare NHS TrustOTHER | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00110006 | Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jun 11, 2010 | clinicaltrials |
| NCT00006261 | Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00298467 | MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma | withdrawn | Phase 2 | 45 | Bristol-Myers SquibbINDUSTRY | 2 | Apr 26, 2010 | clinicaltrials |
| NCT01000896 | Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel | withdrawn | Phase 1 | 27 | AstraZenecaINDUSTRY | 1 | Feb 4, 2010 | clinicaltrials |
| NCT00627627 | A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer | withdrawn | Phase 1 / Phase 2 | 56 | MedImmune LLCINDUSTRY | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00243490 | Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors | withdrawn | Phase 2 | 5 | National Taiwan University HospitalOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00988897 | Colorectal Cancer RECHALLENGE | withdrawn | Phase 2 | 0 | SanofiINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00712621 | Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination | withdrawn | Phase 2 | 460 | American Scitech InternationalOTHER | 1 | Nov 24, 2009 | clinicaltrials |
| NCT00963664 | Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma | withdrawn | Phase 2 | 250 | NeoPlas InnovationOTHER | 1 | Sep 9, 2009 | clinicaltrials |
| NCT00622804 | Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy | withdrawn | Phase 3 | 90 | The Catholic University of KoreaOTHER | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00610792 | Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens | withdrawn | Phase 2 | 91 | Millennium Pharmaceuticals, Inc.INDUSTRY | 2 | Jul 14, 2009 | clinicaltrials |
| NCT00904852 | Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme | withdrawn | Phase 1 | 30 | Millennium Pharmaceuticals, Inc.INDUSTRY | 0 | May 20, 2009 | clinicaltrials |
| NCT00547404 | Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma | withdrawn | Phase 1 | 35 | Piramal Enterprises LimitedINDUSTRY | 0 | Apr 23, 2009 | clinicaltrials |
| NCT00605800 | Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Mar 19, 2009 | clinicaltrials |
| NCT00540332 | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy | withdrawn | Phase 1 / Phase 2 | 0 | Swedish Orphan BiovitrumINDUSTRY | 0 | Mar 2, 2009 | clinicaltrials |
| NCT00209612 | Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. | withdrawn | Phase 1 / Phase 2 | 40 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Feb 17, 2009 | clinicaltrials |
| NCT00718055 | Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients | withdrawn | — | 50 | Copenhagen University Hospital at HerlevOTHER | 1 | Feb 10, 2009 | clinicaltrials |
| NCT00083447 | Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme | withdrawn | Phase 3 | 323 | Xenova BiomedixINDUSTRY | 2 | Jan 7, 2009 | clinicaltrials |
| NCT00347256 | Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer | withdrawn | N/A | 60 | University of TennesseeOTHER | 0 | Dec 10, 2008 | clinicaltrials |
| NCT00485966 | Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia | withdrawn | Phase 2 | 25 | Cylene PharmaceuticalsINDUSTRY | 1 | Nov 5, 2008 | clinicaltrials |
| NCT00594555 | A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia | withdrawn | Phase 2 | 20 | University of CincinnatiOTHER | 1 | Oct 31, 2008 | clinicaltrials |
| NCT00172367 | Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma | withdrawn | Phase 2 | 80 | National Taiwan University HospitalOTHER | 1 | Sep 26, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Jun 9, 2011source: clinicaltrials